Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat

Cardiovascular Research

Volumn 38, Issue 3, 1998, Pages 719-726

  Bayraktutan, Ulvi ^a   Yang, Zhao Kang ^a   Shah, Ajay M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Endothelial factors; Experimental; Heart; Hypertension; Hypertrophy; Molecular biology; Myocytes; Nitric oxide; Rat

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY BLOOD VESSEL; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARDIOMEGALY; CELLS, CULTURED; DROSOPHILA PROTEINS; ENDOTHELIUM, VASCULAR; HYPERTENSION; INSECT PROTEINS; MALE; MYOCARDIUM; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED SHR; RATS, WISTAR; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 0032102780     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00059-5     Document Type: Article

References (51)

1. [1] Nathan C, Xie QW. Nitric oxide synthases: roles, toles and controls. Cell 1994;78:915-918.
2. [2] Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
3. [3] Balligand JL, Kobzik L, Han X, et al. Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;270:14582-14586.
4. [4] Ranjan V, Xiao Z, Diamond SL. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol 1995;269:H550-H555.
5. [5] Inoue N, Venema RC, Sayegh HS, Murphy TJ, Harrison DG. Molecular regulation of the endothelial cell nitric oxide synthase by transforming growth factor-beta. Arterioscler Thromb Vasc Biol 1995;15:1255-1261.
6. [6] Arnal JF, Yamin J, Dockery S, Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA, protein and activity during cell growth. Am J Physiol 1994;267:C1381-C1388.
7. [7] Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-353.
8. [8] Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IA, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-5216.
9. [9] Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993;73:205-209.
10. [10] Liao JK, Shin WS, Lee WY, Clark SL. Oxidised low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-324.
11. [11] McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of cNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994;267:H1921-H1927.
12. [12] Belhassen L, Kelly RA, Smith TW, Balligand JL. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. J Clin Invest 1996;97:1908-1915.
13. [13] Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 1996;31:847-867.
14. [14] Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-380.
15. [15] Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 1991;439:1-14.
16. [16] Grocott-Mason RM, Anning PB, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 1994;267:H1804-H1813.
17. [17] Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119-2162.
18. [18] Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation 1994;89:2070-2078.
19. [19] Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 1993;90:347-351.
20. 2+ current. J Biol Chem 1994;268:26286-26295.
21. [21] Prendergast BD, Sagach VF, Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 1997;96:1320-1329.
22. [22] Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exper Ther 1995;272:945-952.
23. [23] Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW, Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res 1996;78:217-224.
24. [24] Matsuoka H, Nakata M, Kohno K, et al. Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 1996;27:14-18.
25. [25] Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994;75:1086-1095.
26. [26] Kelm M, Feelisch M, Krebber T, Motz W, Strauer BE. The role of nitric oxide in the regulation of coronary vascular ressistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1992;20:S183-S186. suppl. 12.
27. [27] Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
28. [28] Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995;91:2310-2313.
29. [29] Engelman GL, Vitullo JC, Gerrity RG. Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats. Circ Res 1987;60:487-494.
30. [30] Yang CM, Kandaswamy V, Young D, Sen S. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. Cardiovasc Res 1997;36:236-245.
31. [31] Hallbäck-Nordlander M, Noresson E, Thoren P. Hemodynamic consequences of left ventricular hypertrophy in spontaneously hypertensive rats. Am J Cardiol 1979;44:986-993.
32. [32] Ferrario CM, Spech MM, Tarazi RC, Doi Y. Cardiac pumping ability in rats with experimental renal and genetic hypertension. Am J Cardiol 1979;44:979-9985.
33. [33] Shah AM, Mebazaa A, Yang Z-K, et al. Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells. A potential mechanism for matching oxygen supply and demand?. Circ Res 1997;80:688-698.
34. [34] Piper HM, Spahr R, Mertens S, Krutzfeld A, Watanabe, H. Microvascular endothelial cells from heart. In: Piper HM, editor. Cell culture techniques in heart and vessel research. Berlin: Springer-Verlag, 1990:158-177.
35. [35] Porter GA, Palade GE, Milici AJ. Differential binding of the lectins Grifonia simplifolica I and Lycopersicon esculentum to microvascular endothelium: organ specific localisation and partial glycoprotein characterisation. Eur J Cell Biol 1990;51:85-95.
36. [36] Nishida M, Carley WW, Gerritsen ME, Ellingsen O, Kelly RA, Smith TW. Isolation and characterisation of human and rat cardiac microvascular endothelial cells. Am J Physiol 1993;264:H639-H652.
37. [37] Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. 2nd edn., New York: Cold Spring Harbor Laboratory Press, 1989.
38. [38] Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucl Acid Res 1985;13:2485-2502.
39. [39] Colasanti M, Di Pucchio T, Persichini T, Sogos V, Presta M, Lauro GM. Inhibition of inducible nitric oxide synthase mRNA expression by basic fibroblast growth factor in human microglial cells. Neurosc Lett 1995;195:45-48.
40. [40] Bodi I, Bishopric NH, Discher DJ, Wu X, Webster KA. Cell-specificity and signalling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc Res 1995;30:975-984.
41. [41] Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779.
42. [42] Brooksby P, Levi AJ, Jones JV. Investigation of the mechanisms underlying the increased contraction of hypertrophied ventricular myocytes isolated from the spontaneously hypertensive rat. Cardiovasc Res 1993;27:1268-1277.
43. [43] Chevalier B, Heudes D, Heymes C, et al. Trandolapril decreases prevalence of ventricular ectopic activity in middle-aged SHR. Circulation 1995;92:1947-1953.
44. [44] Evans SJ, Levi AJ, Jones JV. Wall stress induced arrhythmia is enhanced by low potassium and early left ventricular hypertrophy in the working rat heart. Cardiovasc Res 1995;29:555-562.
45. [45] Belhassen L, Feron O, Kaye DM, Michel T, Kelly RA. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. J Biol Chem 1997;272:11198-11204.
46. 558. Biochem J 1995;306:141-145.
47. [47] Harrison DG, Sayegh H, Ohara Y, Inoue N, Venema RC. Regulation of expression of the endothelial cell nitric oxide synthase. Clin Exper Pharmacol Physiol 1996;23:251-255.
48. [48] Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-3046.
49. [49] Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 1997;95:104-110.
50. [50] Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
51. [51] Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.